FXR receptor-mediated modulation of cholesterol metabolism

FXR receptor-mediated modulation of cholesterol metabolism

This invention provides methods and compositions that are useful for modulating cholesterol levels in a cell, and for identifying compounds that can tested for ability to modulate cholesterol levels in mammals. In vitro assays for prescreening to identify candidate therapeutic agents for modulation...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Shan, Bei, Okamoto, Arthur
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator Shan, Bei
Okamoto, Arthur
description This invention provides methods and compositions that are useful for modulating cholesterol levels in a cell, and for identifying compounds that can tested for ability to modulate cholesterol levels in mammals. In vitro assays for prescreening to identify candidate therapeutic agents for modulation of cholesterol metabolism are provided. These methods involve analyzing the effect of a test compound on the binding of FXR to a ligand for FXR. Such ligands include, for example, bile acids, coactivators, and corepressors. The methods and compositions involve modulating FXR-mediated expression of genes involved in cholesterol metabolism.
format Patent
fullrecord <record><control><sourceid>uspatents_EFI</sourceid><recordid>TN_cdi_uspatents_applications_20030003520</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>20030003520</sourcerecordid><originalsourceid>FETCH-uspatents_applications_200300035203</originalsourceid><addsrcrecordid>eNrjZLByiwhSKEpNTi0oyS_SzU1NyUwsSU1RyM1PKc1JLMnMz1PIT1NIzsjPSS0uSS3Kz1HITS1JTMrPySzO5WFgTUvMKU7lhdLcDJpuriHOHrqlxQVAQ_JKiuMTCwpyMpPB5hTHGxkYGBsAsamRgTEpagEkCjZP</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>FXR receptor-mediated modulation of cholesterol metabolism</title><source>USPTO Published Applications</source><creator>Shan, Bei ; Okamoto, Arthur</creator><creatorcontrib>Shan, Bei ; Okamoto, Arthur</creatorcontrib><description>This invention provides methods and compositions that are useful for modulating cholesterol levels in a cell, and for identifying compounds that can tested for ability to modulate cholesterol levels in mammals. In vitro assays for prescreening to identify candidate therapeutic agents for modulation of cholesterol metabolism are provided. These methods involve analyzing the effect of a test compound on the binding of FXR to a ligand for FXR. Such ligands include, for example, bile acids, coactivators, and corepressors. The methods and compositions involve modulating FXR-mediated expression of genes involved in cholesterol metabolism.</description><language>eng</language><creationdate>2003</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20030003520$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,776,869,881,64036</link.rule.ids><linktorsrc>$$Uhttps://patentcenter.uspto.gov/applications/10217293$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Shan, Bei</creatorcontrib><creatorcontrib>Okamoto, Arthur</creatorcontrib><title>FXR receptor-mediated modulation of cholesterol metabolism</title><description>This invention provides methods and compositions that are useful for modulating cholesterol levels in a cell, and for identifying compounds that can tested for ability to modulate cholesterol levels in mammals. In vitro assays for prescreening to identify candidate therapeutic agents for modulation of cholesterol metabolism are provided. These methods involve analyzing the effect of a test compound on the binding of FXR to a ligand for FXR. Such ligands include, for example, bile acids, coactivators, and corepressors. The methods and compositions involve modulating FXR-mediated expression of genes involved in cholesterol metabolism.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2003</creationdate><recordtype>patent</recordtype><sourceid>EFI</sourceid><recordid>eNrjZLByiwhSKEpNTi0oyS_SzU1NyUwsSU1RyM1PKc1JLMnMz1PIT1NIzsjPSS0uSS3Kz1HITS1JTMrPySzO5WFgTUvMKU7lhdLcDJpuriHOHrqlxQVAQ_JKiuMTCwpyMpPB5hTHGxkYGBsAsamRgTEpagEkCjZP</recordid><startdate>20030102</startdate><enddate>20030102</enddate><creator>Shan, Bei</creator><creator>Okamoto, Arthur</creator><scope>EFI</scope></search><sort><creationdate>20030102</creationdate><title>FXR receptor-mediated modulation of cholesterol metabolism</title><author>Shan, Bei ; Okamoto, Arthur</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_applications_200300035203</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2003</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Shan, Bei</creatorcontrib><creatorcontrib>Okamoto, Arthur</creatorcontrib><collection>USPTO Published Applications</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Shan, Bei</au><au>Okamoto, Arthur</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>FXR receptor-mediated modulation of cholesterol metabolism</title><date>2003-01-02</date><risdate>2003</risdate><abstract>This invention provides methods and compositions that are useful for modulating cholesterol levels in a cell, and for identifying compounds that can tested for ability to modulate cholesterol levels in mammals. In vitro assays for prescreening to identify candidate therapeutic agents for modulation of cholesterol metabolism are provided. These methods involve analyzing the effect of a test compound on the binding of FXR to a ligand for FXR. Such ligands include, for example, bile acids, coactivators, and corepressors. The methods and compositions involve modulating FXR-mediated expression of genes involved in cholesterol metabolism.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_uspatents_applications_20030003520
source USPTO Published Applications
title FXR receptor-mediated modulation of cholesterol metabolism
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-22T10%3A24%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFI&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Shan,%20Bei&rft.date=2003-01-02&rft_id=info:doi/&rft_dat=%3Cuspatents_EFI%3E20030003520%3C/uspatents_EFI%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true